In AITL lymphoma, multiple mutations in FYN have been detected, which invalidate the inhibitory function of the FYN domain SH2, resulting in a constitutive activation of the tyrosine kinase and T-cell activation44. The gene discussed is FYN; the disease is angioimmunoblastic T-cell lymphoma.